Literature DB >> 24566359

Neonatal diabetes in an infant of diabetic mother: same novel INS missense mutation in the mother and her offspring.

Mehmet Adnan Ozturk, Selim Kurtoglu, Osman Bastug, Levent Korkmaz, Ghaniya Daar, Seyma Memur, Hulya Halis, Tamer Günes, Khalid Hussain, Sian Ellard.   

Abstract

Neonatal diabetes is defined as an uncontrolled hyperglycemic state occurring within the first 6 months of life. It is a rare disease with an incidence of 1 to 90,000-250,000. It is usually a disease of genetic origin in which insulin gene mutations play the main role in the disease process. A baby, born to a mother who had previously been diagnosed with type 1 diabetes mellitus at 14 months of age, had a high blood sugar level within the first few hours after birth and was subsequently diagnosed as having neonatal diabetes mellitus. Baby and mother were identified as having a novel heterozygous insulin missense mutation, p.C109R. Difficulties occurred in both follow-up and feeding of the baby. Without the addition of the mother's milk, an appropriate calorie milk formula and isophane insulin were used for the baby during follow-up. Multiple mechanisms are responsible in the pathogenesis of neonatal diabetes mellitus. Insulin gene mutations are one of the factors in the development of neonatal diabetes mellitus. If a resistant hyperglycemic state persists for a long time among babies, especially in those with intrauterine growth retardation whose mothers are diabetic, the baby concerned should be followed-up carefully for the development of neonatal diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24566359     DOI: 10.1515/jpem-2013-0285

Source DB:  PubMed          Journal:  J Pediatr Endocrinol Metab        ISSN: 0334-018X            Impact factor:   1.634


  2 in total

Review 1.  INS-gene mutations: from genetics and beta cell biology to clinical disease.

Authors:  Ming Liu; Jinhong Sun; Jinqiu Cui; Wei Chen; Huan Guo; Fabrizio Barbetti; Peter Arvan
Journal:  Mol Aspects Med       Date:  2014-12-24

2.  UDP-glucose, cereblon-dependent proinsulin degrader.

Authors:  Jaeyong Cho; Atsushi Miyagawa; Kazuki Yamaguchi; Wakana Abe; Yoji Tsugawa; Hatsuo Yamamura; Takeshi Imai
Journal:  Sci Rep       Date:  2022-08-26       Impact factor: 4.996

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.